z-logo
Premium
Epstein–Barr virus infection negatively impacts the CXCR4‐dependent migration of tonsillar B cells
Author(s) -
EhlinHenriksson Barbro,
Mowafi Frida,
Klein George,
Nilsson Anna
Publication year - 2006
Publication title -
immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.297
H-Index - 133
eISSN - 1365-2567
pISSN - 0019-2805
DOI - 10.1111/j.1365-2567.2005.02311.x
Subject(s) - cd40 , biology , b cell , chemokine , epstein–barr virus , tonsil , chemokine receptor , stromal cell , cxcr4 , virus , naive b cell , cell culture , t cell , virology , immunology , cancer research , in vitro , antigen presenting cell , immune system , antibody , cytotoxic t cell , biochemistry , genetics
Summary The primary Epstein–Barr virus (EBV) infection occurs in the oropharynx, where the virus infects B cells and subsequently establishes latency in the memory B‐cell compartment. EBV has previously been shown to induce changes in the cell surface expression of several chemokine receptors in cell lines and the transfection of EBNA2 or LMP1 into a B‐cell‐lymphoma‐derived cell line decreased the expression of CXCR4. We show that in vitro EBV infection reduces the expression of CXCR4 on primary tonsil B cells already 43 hr after infection. Furthermore, EBV infection affects the chemotactic response to stromal cell‐derived factor (SDF‐1)α/CXCL12, the ligand for CXCR4, with a reduction of SDF‐1α‐induced migration. To clarify whether this reduced migration is EBV‐specific or a consequence of cell activation, tonsillar B cells were either infected with EBV, activated with anti‐CD40 and interleukin‐4 (IL‐4) or kept in medium. Activation by anti‐CD40 and IL‐4 decreased the CXCR4 expression but the CD40 + IL‐4‐stimulated cells showed no reduction of chemotactic efficacy. Our finding suggests that changing the SDF‐1α response of the EBV‐infected B cells may serve the viral strategy by directing the infected cells into the extrafollicular areas, rather than retaining them in the lymphoepithelium.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here